Takeda Shores Up Pipeline Ahead Of Actos Patent Expiry

Japanese pharma also conducting an “overall re-examination” of recently halted TAK-475 cholesterol drug.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet